Changes in copper and zinc status and response to dietary copper deficiency in metallothionein-overexpressing transgenic mouse heart.
Previous studies have shown that cardiac-specific overexpression of metallothionein (MT) inhibits progression of dietary copper restriction-induced cardiac hypertrophy. Because copper and zinc are critically involved in myocardial response to dietary copper restriction, the present study was undertaken to understand the effect of MT on the status of copper and zinc in the heart and the subsequent response to dietary copper restriction. Dams of cardiac-specific MT-transgenic (MT-TG) mouse pups and wild-type (WT) littermates were fed copper-adequate (CuA) or copper-deficient (CuD) diet starting on the fourth day post delivery, and the weanling mice were continued on the same diet until they were sacrificed. Zinc and copper concentrations were significantly elevated in MT-TG mouse heart, but the extent of zinc elevation was much more than that of copper. Dietary copper restriction significantly decreased copper concentrations to the same extent in both MT-TG and WT mouse hearts, and decreased zinc concentrations along with a decrease in MT concentrations in the MT-TG mouse heart. Copper deficiency-induced heart hypertrophy was significantly inhibited, but copper deficiency-induced suppression of serum ceruloplasmin or hepatic Cu,Zn-SOD activities was not inhibited in the MT-TG mice. These results suggest that elevation in zinc but not in copper in the heart may be involved in the MT inhibition of copper deficiency-induced cardiac hypertrophy.
Kang
Y James
YJ
Department of Medicine, University of Louisville School of Medicine, Louisville, KY 40202, USA. yjkang01@louisville.edu
Jiang
Youchun
Y
Saari
Jack T
JT
D000818:Animals; D006332:Cardiomegaly / Q000209:etiology* / Q000378:metabolism; D003300:Copper / Q000172:deficiency* / Q000378:metabolism*; D008668:Metallothionein / Q000096:biosynthesis*; D051379:Mice; D008822:Mice, Transgenic; D009206:Myocardium / Q000378:metabolism*; D015032:Zinc / Q000378:metabolism*
D003300:Copper; D008668:Metallothionein; D015032:Zinc
Proc Soc Exp Biol Med. 1972 Oct;141(1):150-3
4343187
Exp Biol Med (Maywood). 2003 Jul;228(7):811-7
12876300
Methods Enzymol. 1991;205:401-14
1779800
Environ Health Perspect. 1994 Sep;102 Suppl 3:141-6
7843089
Proc Soc Exp Biol Med. 1989 Jan;190(1):121-4
2521393
Proc Soc Exp Biol Med. 1988 Oct;189(1):100-9
2847178
Free Radic Biol Med. 1994 Dec;17(6):529-36
7867969
J Nutr. 2000 May;130(5):1085-8
10801901
Proc Soc Exp Biol Med. 1997 Sep;215(4):299-313
9270715
Acta Biochim Pol. 2004;51(2):471-80
15218543
Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):237-41
8278372
Biochim Biophys Acta. 1986 Dec 10;884(3):448-61
3778934
Mol Aspects Med. 2005 Aug-Oct;26(4-5):299-312
16102805
Clin Chem. 1970 Nov;16(11):903-10
5473551
Exp Biol Med (Maywood). 2006 Oct;231(9):1459-67
17018867
Biochem J. 1984 Apr 1;219(1):1-14
6326753
Lab Invest. 2000 May;80(5):745-57
10830785
Biol Trace Elem Res. 1982 Jun;4(2-3):125-43
24271985
J Clin Invest. 1997 Sep 15;100(6):1501-6
9294117
Neurochem Int. 1995 Jul;27(1):111-7
7655343
Can J Physiol Pharmacol. 2000 Oct;78(10):848-55
11077985
J Nutr. 1993 Nov;123(11):1939-51
8229312
Proc Soc Exp Biol Med. 2000 Mar;223(3):282-7
10719841
Methods Enzymol. 1991;205:83-8
1779827
Methods Enzymol. 1991;205:613-26
1779825
Anal Biochem. 1989 May 15;179(1):8-18
2547324
J Nutr. 2004 Apr;134(4):855-60
15051837